NASDAQ · REAL ESTATE INVESTMENT TRUSTS · SMALL CAP
National Healthcare Properties, Inc. NHP
13 fiscal years on record · USD · FY2025 reported · SEC filings only
Growth
USD 342.3M
Revenue, FY2025 · full 13-year series below
Revenue $M
Net income $M
FY2025 · Revenue 342.3 · Net income -57.7
Compound annual growth
Revenue compounded at −2.2% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−17 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating 1.0% · Net -16.9%
ROE
FY2025 · ROE -9.0%
Each USD of equity lost 9 cents this year.
The 13-year record
13 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.2 | 0.1 | 0.0 |
| Operating income $B | 0.0 | −0.1 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | 0.1 | −0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | −0.0 | 0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 |
| Net income $B | −0.1 | −0.2 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | 0.0 | −0.1 | −0.0 | 0.0 | −0.1 | −0.1 | −0.0 | −0.1 | 0.1 | 0.1 | 0.1 | −0.0 | −0.0 |
| EPS, diluted $ | −2.51 | −7.19 | −3.04 | −3.30 | −0.82 | −0.74 | −0.88 | −0.56 | −0.47 | −0.24 | −0.49 | −0.74 | −0.10 |
| Dividend / sh $ | · | 0.85 | 0.85 | 0.85 | · | 0.42 | 0.83 | 0.92 | 1.51 | 1.70 | 1.70 | 1.70 | 1.03 |
| Payout % | · | · | · | −0 | −0 | −42 | −58 | −105 | −180 | −361 | −159 | −93 | −590 |
| ROE % | −9.0 | −24.1 | −7.7 | −7.9 | −8.6 | −7.3 | −7.5 | −4.1 | −3.0 | −1.4 | −2.5 | −4.0 | −0.1 |
| Shares out B | 0.03 | 0.03 | 0.03 | 0.03 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.01 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 39 reconciliationsAUDITED
Reconciled in 13 of 19 fiscal years. 18 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityReal Estate Investment Trusts
Listed onNASDAQ
Incorporated inMaryland
Fiscal year endsDecember 31
Data on record since2013